International Journal of Pharma Insight Studies is a peer-reviewed journal dedicated to fostering innovation and promoting original research in the fields of pharmaceutical and health sciences. The journal aims to bridge the gap between traditional pharmaceutical practices and emerging trends, fostering dialogue between established methods and cutting-edge advancements in the pharma sector.
Scope: Welcomes research contributions across various subjects in pharmaceutical sciences and allied health disciplines. This includes, but is not limited to, areas such as:
- Pharmacology & Toxicology
- Clinical Pharmacy & Hospital Management
- Drug Discovery & Development
- Medicinal Chemistry
- Biopharmaceutics & Bioavailability Studies
- Pharmaceutical Biotechnology
- Pharmacovigilance & Drug Safety
- Regulatory Affairs & Pharmaceutical Policy
- Pharmacogenomics & Personalized Medicine
- Pharmaceutical Technology & Formulation
- Pharmacoeconomics & Health Outcomes
- Molecular Pharmacology
- Nanotechnology in Drug Delivery
- Clinical Research & Trials
Objective: The journal seeks to provide a platform for scholars, researchers, and industry professionals to present their findings and foster collaboration within the pharmaceutical community. The primary objective is to promote sustainable advancements in drug development, patient care, and public health.
Key Goals:
- To publish high-quality, peer-reviewed original research and review articles.
- To advance understanding of pharmaceutical sciences, improving health outcomes globally.
- To create a knowledge-sharing forum for professionals working in clinical, industrial, and academic sectors.
- To encourage innovation in the development and optimization of pharmaceutical practices and policies.
Publishing and Refund Policy:
- We follows a transparent publishing process with nominal article processing charges.
- Refunds: 30% + transaction charges will be deducted if the author wishes to cancel the publication within 5 days. No refunds will be issued after 5 days or once the article is published.
For any inquiries or further information, please contact us at [[email protected]].